Left Ventricular Function and Aortic Valve Replacement

  • Xu Yu JinEmail author
  • Jiang Ting Hu
  • John R. Pepper


Over the last 50 years, restoring a durable and physiological performance to the aortic valve has been largely accomplished by surgical aortic valve replacement (AVR). The restoration of normal ventricular geometry, mass volume and function is a goal yet to be achieved. More robust management of hypertension, atrial fibrillation and early intervention in asymptomatic aortic stenosis (AS) or aortic regurgitation (AR) may offer a better outcome. This requires a comprehensive physiological consideration that combines classical force-velocity relationship and the time course of force development. Left ventricular hypertrophy (LVH) and myocardial fibrosis remain structural and morphological focus points in this process. Classical ECG strain pattern, CMR mapping of fibrosis and 3D speckle tracking echocardiography along with functional genomics are creating a new platform to yield more in-depth understanding of the nature of myocardial adaptation to pressure and volume overloading in heart valve diseases and myocardial response to valve surgery or intervention. Ultimately the physiological principles, the new knowledge and novel valve prostheses will work in synergy to improve quality of life in an ageing population.


Aortic valve replacement TAVI Left ventricular function Left ventricular hypertrophy regression Myocardial force-velocity relationship Myocardial power Ventricular incoordination Cardiac genomic physiology 


  1. 1.
    Gaasch W, Andrias W, Levine HJ. Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function. Circulation. 1978;58:825–36.PubMedCrossRefGoogle Scholar
  2. 2.
    Borer JS, Herrold EM, Hochreither C, Roma M, Supino P, Devereux RB, Kligfield P, Nawaz H, Chlouverakis G. Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation. Circulation. 1991;84:S133–9.Google Scholar
  3. 3.
    Jin XY, Pepper JR, Brecker SJ, Carey JA, Gibson DG. Early changes in left ventricular function after aortic valve replacement for isolated aortic stenosis. Am J Cardiol. 1994;74:1142–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Jin XY, Westaby S, Gibson DG, Pillai R, Taggart D. Left ventricular remodelling and improvement in freestyle stentless valve haemodynamics. Eur J Cardiothorac Surg. 1997;12:63–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Jin XY, Zhang ZM, Gibson DG, Yacoub MH, Pepper JR. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg. 1996;62:683–90.CrossRefGoogle Scholar
  6. 6.
    Dworakowski R, Wendler O, Bhan A, Smith L, Pearson P, Alcock E, Rajagopal K, Brickham B, Dew T, Byrne J, Monaghan MJ, Sherwood R, Shah AM. Successful transcatheter aortic valve implantation (TAVI) is associated with transient left ventricular dysfunction. Heart. 2012;98:1641–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Ribeiro HB, Nombela-Franco L, Munoz-Garcia AJ, Lemos PA, Amat-Santos I, Serra V, et al. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves. J Thorac Cardiovasc Surg. 2004;127:149–59.CrossRefGoogle Scholar
  8. 8.
    Austen WG, Corning HB, Moran JM, Sanders CA, Scannell JG. Cardiac hemodynamics immediately following aortic valve surgery. J Thorac Cardiovasc Surg. 1966;51:461–7.PubMedGoogle Scholar
  9. 9.
    Carey JS, Plested WG. Immediate hemodynamic response to correction of cardiac valvular lesions. Ann Thorac Surg. 1972;13:311–23.PubMedCrossRefGoogle Scholar
  10. 10.
    Harpole DH, Jones RH. Serial assessment of ventricular performance after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg. 1990;99:645–50.PubMedGoogle Scholar
  11. 11.
    Pantely G, Morton M, Rahimtoola SH. Effects of successful, uncomplicated valve replacement on ventricular hypertrophy, volume, and performance in aortic stenosis and in aortic incompetence. J Thorac Cardiovasc Surg. 1978;75:383–91.PubMedGoogle Scholar
  12. 12.
    Parikh R, Goodman AL, Barr T, Sabik JF, Svensson LG, Rodriguez LL, Lytle BW, et al. Outcomes of surgical aortic valve replacement for severe aortic stenosis: incorporation of left ventricular systolic function and stroke volume index. J Thorac Cardiovasc Surg. 2015;149:1558–66.PubMedCrossRefGoogle Scholar
  13. 13.
    Eleid MF, Goel K, Murad MH, Erwin PJ, Suri RM, Greason KL, et al. Meta-analysis of the prognostic impact of stroke volume, gradient, and ejection fraction after transcatheter aortic valve implantation. Am J Cardiol. 2015;116:989–94.PubMedCrossRefGoogle Scholar
  14. 14.
    Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56–64.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Quinones MA, Gaasch WH, Cole JS, Alexander JK. Echocardiographic determination of left ventricular stress-velocity relations in man. With reference to the effects of loading and contractility. Circulation. 1975;51:689–700.PubMedCrossRefGoogle Scholar
  16. 16.
    Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis. 1976;18:255–64.PubMedCrossRefGoogle Scholar
  17. 17.
    Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59:679–88.PubMedCrossRefGoogle Scholar
  18. 18.
    Henry WL, Bonow RO, Borer JS, Kent KM, Ware JH, Redwood DR, Itscoitz SB, McIntosh CL, Morrow AG. Evaluation of aortic valve replacement in patients with valve aortic stenosis. Circulation. 1980;61:814–25.PubMedCrossRefGoogle Scholar
  19. 19.
    Starling MR, Kirsh MM, Montgomery DG, Gross MD. Mechanisms for left ventricular systolic dysfunction in aortic regurgitation: importance for predicting the functional response to aortic valve replacement. J Am Coll Cardiol. 1991;17:887–97.PubMedCrossRefGoogle Scholar
  20. 20.
    Pirwitz MJ, Lange RA, Willard JE, Landau C, Glamann B, Hillis LD. Use of the left ventricular peak systolic pressure/end-systolic volume ratio to predict symptomatic improvement with valve replacement in patients with aortic regurgitation and enlarged end-systolic volume. J Am Coll Cardiol. 1994;24:1672–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Taniguchi K, Nakano S, Kawashima Y, Sakai K, Kawamoto T, Sakaki S, Kobayashi J, Morimoto S, Matsuda H. Left ventricular ejection performance, wall stress, and contractile state in aortic regurgitation before and after aortic valve replacement. Circulation. 1990;82:798–807.PubMedCrossRefGoogle Scholar
  22. 22.
    Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation. 1978;58:255–64.PubMedCrossRefGoogle Scholar
  23. 23.
    St J, Sutton M, Plappert T, Spiegel A, Raichlen J, Douglas P, Reichek N, Edmunds L. Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: a prospective two-dimensional echocardiographic study. Circulation. 1987;76:77–89.CrossRefGoogle Scholar
  24. 24.
    Ren JF, Panidis IP, Kotler MN, Mintz GS, Goel I, Ross J. Effect of coronary bypass surgery and valve replacement on left ventricular function: assessment by intraoperative two-dimensional echocardiography. Am Heart J. 1985;109:281–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Venco A, St J, Sutton MG, Gibson DG, Brown DJ. Non-invasive assessment of left ventricular function after correction of severe aortic regurgitation. Br Heart J. 1976;38:1324–31.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Roman MJ, Klein L, Devereux RB, Kligfield P, Niles NW, Hochreiter C, Isom W, Borer JS. Reversal of left ventricular dilatation, hypertrophy, and dysfunction by valve replacement in aortic regurgitation. Am Heart J. 1989;118:553–63.PubMedCrossRefGoogle Scholar
  27. 27.
    Bonow RO. Regional left ventricular nonuniformity. Effects on left ventricular diastolic function in ischemic heart disease, hypertrophic cardiomyopathy, and the normal heart. Circulation. 1990;81:S54–65.Google Scholar
  28. 28.
    Nishimura RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. J Am Coll Cardiol. 2014;22:2438–88.CrossRefGoogle Scholar
  29. 29.
    Jin XY, Pepper JR, Xiao HB, Gibson DG. Effect of abnormal activation on the development of left ventricular incoordination in aortic valve disease (abstract). Circulation. 1996;94:I-668.Google Scholar
  30. 30.
    Wiggers CJ. The interpretation of the intraventricular pressure curve on the basis of rapid summated fractionate contractions. Am J Phys. 1927;80:1–30.CrossRefGoogle Scholar
  31. 31.
    Heyndrickx G, Vilaine JP, Knight DR, Vatner SF. Effects of altered site of electrical activation on myocardial performance during inotropic stimulation. Circulation. 1985;71:1010–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Ford LE. Effect of afterload reduction on myocardial energetics. Circ Res. 1980;46:161–6.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Chiu YC, Walley KR, Ford LE. Comparison of the effects of different inotropic interventions on force, velocity, and power in rabbit myocardium. Circ Res. 1989;65:1161–71.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Katz LN, Feil HS. Clinical observations on the dynamics of ventricular systole: III. Aortic stenosis and aortic insufficiency. Heart. 1926;12:171–80.Google Scholar
  35. 35.
    Moskowitz RL, Wechsler BM. Left ventricular ejection time in aortic and mitral valve disease. Am J Cardiol. 1965;15:809–14.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Jin XY, Pepper JR, Gibson DG, Yacoub MY. Early changes in the time course of myocardial contraction after correcting aortic regurgitation. Ann Thorac Surg. 1999;67:139–45.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Jin XY, Pepper J. Severe left ventricular hypertrophy(LVH) indicates the failure of myocardial adaptation in aortic stenosis. Heart. 2005;91:A71.Google Scholar
  38. 38.
    Jin XY, Pepper J. Mechanical determinants of left ventricular hypertrophy in patients with heart valve diseases. Heart. 2015;101:A28–9.CrossRefGoogle Scholar
  39. 39.
    Grossman W, Paulus WJ. Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling. J Clin Invest. 2013;123:3701–3.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Jin XY, Hu J, Pezzella F, Pepper JR. The critical role of ERBB2 in human left ventricular remodelling due to pressure or volume overload. Heart. 2007;93:A18–9.Google Scholar
  41. 41.
    Gibson DG, Traill TA, Hall RJC, Brown DJ. Echocardiographic features of secondary left ventricular hypertrophy. Br Heart J. 1979;41:54–9.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Vanoverschelde JLJ, Essamri B, Michel X, Hanet C, Cosyns JR, Detry JMR, Wijns W. Hemodynamic and volume correlates of left ventricular diastolic relaxation and filling in patients with aortic stenosis. J Am Coll Cardiol. 1992;20:813–21.PubMedCrossRefGoogle Scholar
  43. 43.
    Hess OM, Villari B, Krayenbuehl HP. Diastolic dysfunction in aortic stenosis. Circulation. 1993;87:S73–6.Google Scholar
  44. 44.
    Villari B, Sossalla S, Ciampi Q, Petruzziello B, Turina J, Schneider J, Turina M, Hess OM. Persistent diastolic dysfunction late after valve replacement in severe aortic regurgitation. Circulation. 2009;120:2386–92.PubMedCrossRefGoogle Scholar
  45. 45.
    Gjertsson P, Caidahl K, Bech-Hanssen O. Left ventricular diastolic dysfunction late after aortic valve replacement in patients with aortic stenosis. Am J Cardiol. 2005;9:722–7.CrossRefGoogle Scholar
  46. 46.
    Gjertsson P, Caidahl K, Farasati M, Odén A, Bech-Hanssen O. Preoperative moderate to severe diastolic dysfunction: a novel Doppler echocardiographic long-term prognostic factor in patients with severe aortic stenosis. J Thorac Cardiovasc Surg. 2005;129:890–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate and late after aortic valve replacement. Acta Cardiol. 1992;47:145–56.Google Scholar
  48. 48.
    Jin XY. Elucidation of cardiac physiology in aortic valve replacement: what should we know? J Heart Valve Dis. 2004;13:S70–5.PubMedGoogle Scholar
  49. 49.
    Lund O. Valve replacement for aortic stenosis: the curative potential of early operation. Scand J Thorac Cardiovasc Surg. 1993;40:S1–137.Google Scholar
  50. 50.
    Fuster RG, Argudo JA, Albarova OG, Sos FH, López SC, Sorlí MJ, Codoñer MB, Miñano JA. Left ventricular mass index in aortic valve surgery: a new index for early valve replacement? Eur J Cardiothorac Surg. 2003;23:696–702.PubMedCrossRefGoogle Scholar
  51. 51.
    Ruel M, Rubens FD, Masters RG, Pipe AL, Bédard P, Hendry PJ, Lam BK, Burwash IG, Goldstein WG, Brais MP, Keon WJ, Mesana TG. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves. J Thorac Cardiovasc Surg. 2004;127:149–59.PubMedCrossRefGoogle Scholar
  52. 52.
    Brown ML, Pellikka PA, Schaff HV, Scott CG, Mullany CJ, Sundt TM, Dearani JA, Daly RC, Orszulak TA. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg. 2008;135:308–15.PubMedCrossRefGoogle Scholar
  53. 53.
    Beach JM, Mihaljevic T, Rajeswaran J, Marwick T, Edwards ST, Nowicki ER, Thomas J, Svensson LG, Griffin B, Gillinov AM, Blackstone EH. Ventricular hypertrophy and left atrial dilatation persist and are associated with reduced survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg. 2014;147:362–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Knöll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D, Bauersachs J, Leite-Moreira AF, Sugden PH, Balligand JL. Towards a re-definition of ‘cardiac hypertrophy’ through a rational characterization of left ventricular phenotypes: a position paper of the Working Group ‘Myocardial Function’ of the ESC. Eur J Heart Fail. 2011;13:811–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Vliegen HW, van der Laarse A, Cornelisse CJ, Eulderink F. Myocardial changes in pressure overload-induced left ventricular hypertrophy. A study on tissue composition, polyploidization and multinucleation. Eur Heart J. 1991;12:488–94.PubMedCrossRefGoogle Scholar
  56. 56.
    Lund O, Emmertsen K, Dørup I, Jensen FT, Flø C. Regression of left ventricular hypertrophy during 10 years after valve replacement for aortic stenosis is related to the preoperative risk profile. Eur Heart J. 2003;24:1437–46.PubMedCrossRefGoogle Scholar
  57. 57.
    Mehta RH, Bruckman D, Das S, Tsai T, Russman P, Karavite D, Monaghan H, Sonnad S, Shea MJ, Eagle KA, Deeb GM. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg. 2001;122:919–28.PubMedCrossRefGoogle Scholar
  58. 58.
    Duncan AI, Lowe BS, Garcia MJ, Xu M, Gillinov AM, Mihaljevic T, Koch CG. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg. 2008;85:2030–9.PubMedCrossRefGoogle Scholar
  59. 59.
    van Straten AH, Soliman Hamad MA, Peels KC, van den Broek KC, ter Woorst JF, Elenbaas TW, van Dantzig JM. Increased septum wall thickness in patients undergoing aortic valve replacement predicts worse late survival. Ann Thorac Surg. 2012;94:66–71.PubMedCrossRefGoogle Scholar
  60. 60.
    Milano AD, Faggian G, Dodonov M, Golia G, Tomezzoli A, Bortolotti U, Mazzucco A. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. J Thorac Cardiovasc Surg. 2012;144:830–7.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68:1560–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Mihaljevic T, Nowicki ER, Rajeswaran J, Blackstone EH, Lagazzi L, Thomas J, Lytle BW, Cosgrove DM. Survival after valve replacement for aortic stenosis: implications for decision making. J Thorac Cardiovasc Surg. 2008;135:1270–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Jin XY, Pillai R, Westaby S. Medium-term determinants of left ventricular mass index after stentless aortic valve replacement. Ann Thorac Surg. 1999;67:411–6.PubMedCrossRefGoogle Scholar
  64. 64.
    Del Rizzo DF, Abdoh A, Cartier P, Doty D, Westaby S. Factors affecting left ventricular mass regression after aortic valve replacement with stentless valves. Semin Thorac Cardiovasc Surg. 1999;11:S114–20.Google Scholar
  65. 65.
    Mohty D, Dumesnil JG, Echahidi N, Mathieu P, Dagenais F, Voisine P, Pibarot P. Impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: influence of age, obesity, and left ventricular dysfunction. J Am Coll Cardiol. 2009;53:39–47.CrossRefGoogle Scholar
  66. 66.
    Head SJ, Mokhles MM, Osnabrugge RL, Pibarot P, Mack MJ, Takkenberg JJ, Bogers AJ, Kappetein AP. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J. 2012;33:1518–29.CrossRefGoogle Scholar
  67. 67.
    Jin XY, Westaby S. In vivo haemodynamic characteristics of porcine stentless aortic valves. Semin Thorac Cardiovasc Surg. 2001;13:S67–74.Google Scholar
  68. 68.
    Jin XY, Westaby S. Pericardial and porcine stentless aortic valves: are they hemodynamically different? Ann Thorac Surg. 2001;71:S311–4.PubMedCrossRefGoogle Scholar
  69. 69.
    Pillai R, Kattach H, Soon JL, Ratnatunga C, Jin XY. 3F prosthesis aortic cusp replacement: implantation technique and early results. Asian Ann Cardiovasc Med Surg. 2010;18:13–6.CrossRefGoogle Scholar
  70. 70.
    Westaby S, Horton M, Jin XY, Katsumata T, Li H, Grunkemeir G. Survival advantage of stentless aortic bioprosthesis. Ann Thorac Surg. 2000;70:785–90.CrossRefGoogle Scholar
  71. 71.
    Kunadian B, Vijayalakshmi K, Thornley AR, de Belder MA, Hunter S, Kendall S, Graham R, Stewart M, Thambyrajah J, Dunning J. Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. Ann Thorac Surg. 2007;84:73–8.CrossRefGoogle Scholar
  72. 72.
    Jin XY, Ratnatunga C. Invited commentary on “A meta-analysis of valve hemodynamics and LV mass regression for stentless versus stented aortic valves”. Ann Thorac Surg. 2007;84:78–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Cohen G, Zagorski B, Christakis GT, Joyner CD, Vincent J, Sever J, Harbi S, Feder-Elituv R, Moussa F, Goldman BS, Fremes SE. Are stentless valves hemodynamically superior to stented valves? Long-term follow-up of a randomized trial comparing Carpentier-Edwards pericardial valve with the Toronto Stentless Porcine Valve. J Thorac Cardiovasc Surg. 2010;139:848–59.CrossRefGoogle Scholar
  74. 74.
    Dayan V, Vignolo G, Soca G, Paganini JJ, Brusich D, Pibarot P. Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 2016;9:924–33.PubMedCrossRefGoogle Scholar
  75. 75.
    Gaudino M, Alessandrini F, Glieca F, Luciani N, Cellini C, Pragliola C, Morelli M, Canosa C, Nasso G, Possati G. Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate? Eur Heart J. 2005;26:51–7.PubMedCrossRefGoogle Scholar
  76. 76.
    Westaby S, Jin XY, Katsumata T, Arifi A, Braidley P. Valve replacement with a stentless bioprosthesis: versatility of the porcine aortic root. J Thorac Cardiovasc Surg. 1998;116:477–84.CrossRefGoogle Scholar
  77. 77.
    Bové T, Van Belleghem Y, François K, Caes F, Van Overbeke H, Van Nooten G. Stentless and stented aortic valve replacement in elderly patients: factors affecting midterm clinical and hemodynamical outcome. Eur J Cardiothorac Surg. 2006;30:706–13.PubMedCrossRefGoogle Scholar
  78. 78.
    Imanaka K, Kohmoto O, Nishimura S, Yokote Y, Kyo S. Impact of postoperative blood pressure control on regression of left ventricular mass following valve replacement for aortic stenosis. Eur J Cardiothorac Surg. 2005;27:994–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Tjang YS, van Hees Y, Körfer R, Grobbee DE, van der Heijden GJ. Predictors of mortality after aortic valve replacement. Eur J Cardiothorac Surg. 2007;32:469–74.PubMedCrossRefGoogle Scholar
  80. 80.
    Tzikas A, Geleijnse ML, Van Mieghem NM, Schultz CJ, Nuis RJ, van Dalen BM, Sarno G, van Domburg RT, Serruys PW, de Jaegere PP. Left ventricular mass regression one year after transcatheter aortic valve implantation. Ann Thorac Surg. 2011;91:685–91.PubMedCrossRefGoogle Scholar
  81. 81.
    Schueler R, Sinning JM, Momcilovic D, Weber M, Ghanem A, Werner N, Nickenig G, Grube E, Hammerstingl C. Three-dimensional speckle-tracking analysis of left ventricular function after transcatheter aortic valve implantation. J Am Soc Echocardiogr. 2012;25:827–34.PubMedCrossRefGoogle Scholar
  82. 82.
    Hahn RT, Pibarot P, Stewart WJ, Weissman NJ, Gopalakrishnan D, Keane MG, Anwaruddin S, et al. Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort a of the PARTNER trial (placement of aortic transcatheter valves). J Am Coll Cardiol. 2013;61:2514–21.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012;126:720–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, et al. PARTNER Publications Office. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart. 2015;101:1665–71.PubMedCrossRefGoogle Scholar
  85. 85.
    Massoullié G, Bordachar P, Ellenbogen KA, Souteyrand G, Jean F, Combaret N, Vorilhon C, Clerfond G, Farhat M, Ritter P, Citron B, Lusson JR, Motreff P, Ploux S, Eschalier R. New-onset left bundle branch block induced by transcutaneous aortic valve implantation. Am J Cardiol. 2016;117:867–73.PubMedCrossRefGoogle Scholar
  86. 86.
    Magalhaes MA, Koifman E, Torguson R, Minha S, Gai J, Kiramijyan S, Escarcega RO, Baker NC, Wang Z, Goldstein S, Asch F, Satler LF, Pichard AD, Waksman R. Outcome of left-sided cardiac remodeling in severe aortic stenosis patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2015;116:595–603.PubMedCrossRefGoogle Scholar
  87. 87.
    Jin XY, Pepper JR, Gibson DG. Effects of incoordination on left ventricular force-velocity relation in aortic stenosis. Heart. 1996;76:495–501.PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Kvidal P, Bergström R, Hörte LG, Ståhle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol. 2000;35:747–56.PubMedCrossRefGoogle Scholar
  89. 89.
    Gotzmann M, Lindstaedt M, Mügge A. From pressure overload to volume overload: aortic regurgitation after transcatheter aortic valve implantation. Am Heart J. 2012;163:903–11.PubMedCrossRefGoogle Scholar
  90. 90.
    Poulin F, Carasso S, Horlick EM, Rakowski H, Lim KD, Finn H, Feindel CM, Greutmann M, Osten MD, Cusimano RJ, Woo A. Recovery of left ventricular mechanics after transcatheter aortic valve implantation: effects of baseline ventricular function and postprocedural aortic regurgitation. J Am Soc Echocardiogr. 2014;27:1133–42.PubMedCrossRefGoogle Scholar
  91. 91.
    Falk V. Transcatheter aortic valve replacement indications should not be expanded to lower-risk and younger patients. Circulation. 2014;130:2332–42.PubMedCrossRefGoogle Scholar
  92. 92.
    Carabello BA, Usher BW, Hendrix GH, Assey ME, Crawford FA, Leman RB. Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: a change in the measuring stick. J Am Coll Cardiol. 1987;10:991–7.PubMedCrossRefGoogle Scholar
  93. 93.
    Borer JS. Aortic valve replacement for the asymptomatic patient with aortic regurgitation: a new piece of the strategic puzzle. Circulation. 2002;106:2637–9.PubMedCrossRefGoogle Scholar
  94. 94.
    Brown ML, Schaff HV, Suri RM, Li Z, Sundt TM, Dearani JA, Daly RC, Orszulak TA. Indexed left ventricular dimensions best predict survival after aortic valve replacement in patients with aortic valve regurgitation. Ann Thorac Surg. 2009;87:1170–5.PubMedCrossRefGoogle Scholar
  95. 95.
    Shah PK. Should severe aortic stenosis be operated on before symptom onset? Severe aortic stenosis should not be operated on before symptom onset. Circulation. 2012;126:118–25.PubMedCrossRefGoogle Scholar
  96. 96.
    Carabello BA. Should severe aortic stenosis be operated on before symptom onset? Aortic valve replacement should be operated on before symptom onset. Circulation. 2012;126:112–7.PubMedCrossRefGoogle Scholar
  97. 97.
    Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, et al; CURRENT AS Registry Investigators. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66:2827–38.PubMedCrossRefGoogle Scholar
  98. 98.
    Zilberszac R, Gabriel H, Schemper M, Laufer G, Maurer G, Rosenhek R. Asymptomatic severe aortic stenosis in the elderly. JACC Cardiovasc Imaging. 2017;10:43–50.PubMedCrossRefGoogle Scholar
  99. 99.
    Chin CW, Messika-Zeitoun D, Shah AS, Lefevre G, Bailleul S, Yeung EN, Koo M, Mirsadraee S, Mathieu T, Semple SI, Mills NL, Vahanian A, Newby DE, Dweck MR. A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis. Eur Heart J. 2016;37:713–23.PubMedCrossRefGoogle Scholar
  100. 100.
    Kearney LG, Lu K, Ord M, Patel SK, Profitis K, Matalanis G, Burrell LM, Srivastava PM. Global longitudinal strain is a strong independent predictor of all-cause mortality in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging. 2012;13:827–33.PubMedCrossRefGoogle Scholar
  101. 101.
    Yingchoncharoen T, Gibby C, Rodriguez LL, Grimm RA, Marwick TH. Association of myocardial deformation with outcome in asymptomatic aortic stenosis with normal ejection fraction. Circ Cardiovasc Imaging. 2012;5:719–25.PubMedCrossRefGoogle Scholar
  102. 102.
    Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, Kapoun AM, Zheng Q, Protter AA, Schreiner GF, White RT. Altered patterns of gene expression in response to myocardial infarction. Circ Res. 2000;86:939–45.PubMedCrossRefGoogle Scholar
  103. 103.
    Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L, Mitchell CA, Young JB, Francis GS, McCarthy PM, Bond M. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation. 2000;102:3046–52.PubMedCrossRefGoogle Scholar
  104. 104.
    Yang J, Brown ME, Zhang H, Martinez M, Zhao Z, Bhutani S, Yin S, Trac D, Xi JJ, Davis ME. High-throughput screening identifies microRNAs that target Nox2 and improve function after acute myocardial infarction. Am J Physiol Heart Circ Physiol. 2017;312:H1002–H12.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Qiao A, Zhao Z, Zhang H, Sun Z, Cui X. Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies. Pathol Res Pract. 2017;213:548–57.PubMedCrossRefGoogle Scholar
  106. 106.
    Wang H, Kwak D, Fassett J, Hou L, Xu X, Burbach BJ, Thenappan T, Xu Y, Ge JB, Shimizu Y, Bache RJ, Chen Y. CD28/B7 deficiency attenuates systolic overload-induced congestive heart failure, myocardial and pulmonary inflammation, and activated T cell accumulation in the heart and lungs. Hypertension. 2016;68:688–96.PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Balakumar P, Jagadeesh G. Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared? Pharmacol Res. 2010;62:365–83.PubMedCrossRefGoogle Scholar
  108. 108.
    Pasipoularides A. Calcific aortic valve disease: Part 1—molecular pathogenetic aspects, hemodynamics, and adaptive feedbacks. J Cardiovasc Transl Res. 2016;9:102–18.PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Pasipoularides A. Calcific aortic valve disease: Part 2—morphomechanical abnormalities, gene reexpression, and gender effects on ventricular hypertrophy and its reversibility. J Cardiovasc Transl Res. 2016;9:374–99.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation. 2012;125:346–53.PubMedCrossRefGoogle Scholar
  111. 111.
    Shah AS, Chin CW, Vassiliou V, Cowell SJ, Doris M, Kwok TC, Semple S, Zamvar V, White AC, McKillop G, Boon NA, Prasad SK, Mills NL, Newby DE, Dweck MR. Left ventricular hypertrophy with strain and aortic stenosis. Circulation. 2014;130:1607–16.PubMedCrossRefGoogle Scholar
  112. 112.
    Du X, Jin XY. The time course of improvement in ECG strain pattern after AVR for aortic stenosis and its underlying mechanisms. Heart. 2007;93:A39.CrossRefGoogle Scholar
  113. 113.
    Jin XY, Yuan L, Hu JT, Pepper JR. The simultaneous changes in ECG strain pattern and left ventricular force-velocity relationship immediately after valve replacement for aortic stenosis. Heart. 2013;99:A87.Google Scholar
  114. 114.
    Hu JT, Pepper J, Pezzella F, Gatter K, Jin XY. Genomic insights of ECG strain patten in aortic stenosis: T wave inversion and ST-segment depression are underlined by different molecular pathways. Heart. 2017;103:A97.Google Scholar
  115. 115.
    Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation. 2002;106:130–5.PubMedCrossRefGoogle Scholar
  116. 116.
    Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem. 1995;270:10915–22.PubMedCrossRefGoogle Scholar
  117. 117.
    López B, González A, Querejeta R, Barba J, Díez J. Association of plasma cardiotrophin-1 with stage C heart failure in hypertensive patients: potential diagnostic implications. J Hypertens. 2009;27:418–24.PubMedCrossRefGoogle Scholar
  118. 118.
    Huang-Lee LL, Nimni ME. Fibroblast contraction of collagen matrices with and without covalently bound hyaluronan. J Biomater Sci Polym Ed. 1993;5:99–109.PubMedCrossRefGoogle Scholar
  119. 119.
    Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation. 2006;113:2089–96.PubMedCrossRefGoogle Scholar
  120. 120.
    González A, López B, Querejeta R, Zubillaga E, Echeverría T, Díez J. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction. Hypertension. 2010;55:1418–24.PubMedCrossRefGoogle Scholar
  121. 121.
    Melendez-Zajgla J, Del Pozo L, Ceballos G, Maldonado V. Tissue inhibitor of metalloproteinases-4. The road less traveled. Mol Cancer. 2008;7:85.PubMedPubMedCentralCrossRefGoogle Scholar
  122. 122.
    Yarbrough WM, Mukherjee R, Ikonomidis JS, Zile MR, Spinale FG. Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications. J Thorac Cardiovasc Surg. 2012;143:656–64.PubMedPubMedCentralCrossRefGoogle Scholar
  123. 123.
    Dahl JS, Videbaek L, Poulsen MK, Pellikka PA, Veien K, Andersen LI, Haghfelt T, Møller JE. Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis. Am J Cardiol. 2010;106:713–9.PubMedCrossRefGoogle Scholar
  124. 124.
    Benedetto U, Melina G, Refice S, di Bartolomeo R, Roscitano A, Angeloni E, Sinatra R. Dual renin-angiotensin system blockade for patients with prosthesis-patient mismatch. Ann Thorac Surg. 2010;90:1899–903.PubMedCrossRefGoogle Scholar
  125. 125.
    Coffey S, Williams MJ, Phillips LV, Galvin IF, Bunton RW, Jones GT. Integrated microRNA and messenger RNA analysis in aortic stenosis. Sci Rep. 2016;6:36904.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Surgical Echo-Cardiology and Genomics Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of MedicineUniversity of OxfordOxfordUK
  2. 2.Department of Cardiothoracic Surgery, Oxford Heart Centre, John Radcliffe HospitalOxford University Hospitals NHS Foundation TrustOxfordUK
  3. 3.Academic Cardiac Surgery, Royal Brompton HospitalImperial College LondonLondonUK

Personalised recommendations